We are live on ! Find out more
CS

Credit Suisse Portfolio holdings

AUM $104B
1-Year Est. Return 34.76%
This Fund
S&P 500
This Quarter Est. Return
+8.7%
1 Year Est. Return
+34.76%
3 Year Est. Return
+49.35%
5 Year Est. Return
+181.01%
10 Year Est. Return
+395.52%
AUM
$189B
AUM Growth
-$6.65B
Cap. Flow
-$21B
Cap. Flow %
-11.12%
Top 10 Hldgs %
16.9%
Holding
4,784
New
635
Increased
1,494
Reduced
2,137
Closed
388

Sector Composition

Rank Sector Weight
1 Technology 14.66%
2 Healthcare 11.06%
3 Financials 8.17%
4 Consumer Discretionary 8.09%
5 Communication Services 6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PHAT icon
4101
Phathom Pharmaceuticals
PHAT
$686M
$224K ﹤0.01%
6,599
+1,233
+23% +$44.2K
PNQI icon
4102
Invesco NASDAQ Internet ETF
PNQI
$536M
$223K ﹤0.01%
+4,350
New +$209K
SSTI icon
4103
SoundThinking
SSTI
$103M
$223K ﹤0.01%
+4,564
New +$175K
SUSA icon
4104
iShares ESG Optimized MSCI USA ETF
SUSA
$4.12B
$223K ﹤0.01%
+2,333
New +$216K
IYF icon
4105
iShares US Financials ETF
IYF
$4.61B
$222K ﹤0.01%
2,740
-24,354
-90% -$1.96M
RSPN icon
4106
Invesco S&P 500 Equal Weight Industrials ETF
RSPN
$1.13B
$222K ﹤0.01%
+5,950
New +$221K
BDSI
4107
DELISTED
BioDelivery Sciences International, Inc.
BDSI
$222K ﹤0.01%
62,367
+706
+1% +$2.49K
BMRC icon
4108
Bank of Marin Bancorp
BMRC
$480M
$221K ﹤0.01%
6,966
-2,155
-24% -$75.4K
VIG icon
4109
Vanguard Dividend Appreciation ETF
VIG
$113B
$221K ﹤0.01%
+1,426
New +$219K
MASS icon
4110
908 Devices
MASS
$361M
$220K ﹤0.01%
+5,701
New +$258K
MOS icon
4111
PUT
The Mosaic Company
MOS
$6.95B
$219K ﹤0.01%
7,100
SCR
4112
DELISTED
Score Media and Gaming Inc. Class A Subordinate Voting Shares
SCR
$219K ﹤0.01%
+10,955
New +$207K
BLBD icon
4113
Blue Bird Corp
BLBD
$2.42B
$217K ﹤0.01%
8,754
-815
-9% -$21.4K
EMDV icon
4114
ProShares MSCI Emerging Markets Dividend Growers ETF
EMDV
$7.36M
$217K ﹤0.01%
3,562
-2,626
-42% -$160K
IHI icon
4115
CALL
iShares US Medical Devices ETF
IHI
$3.34B
$217K ﹤0.01%
3,600
-4,800
-57% -$278K
TCRR
4116
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
$217K ﹤0.01%
13,245
-11,124
-46% -$225K
CMBM
4117
DELISTED
Cambium Networks
CMBM
0
IWP icon
4118
iShares Russell Mid-Cap Growth ETF
IWP
$20.4B
$216K ﹤0.01%
+1,907
New +$204K
PLRX icon
4119
Pliant Therapeutics
PLRX
$65M
$216K ﹤0.01%
7,464
-728
-9% -$22.7K
SAN icon
4120
Banco Santander
SAN
$208B
$215K ﹤0.01%
+54,696
New +$212K
PAVE icon
4121
Global X US Infrastructure Development ETF
PAVE
$14.9B
$211K ﹤0.01%
+8,200
New +$213K
KODK icon
4122
Kodak
KODK
$841M
$210K ﹤0.01%
24,337
-13,614
-36% -$107K
GEL icon
4123
Genesis Energy
GEL
$1.85B
$209K ﹤0.01%
19,006
-1,501
-7% -$15.2K
KNSA icon
4124
Kiniksa Pharmaceuticals
KNSA
$5.88B
$209K ﹤0.01%
15,005
-2,418
-14% -$36.7K
EVA
4125
DELISTED
Enviva Inc.
EVA
$208K ﹤0.01%
3,964
-247
-6% -$12.2K

Similar funds

Credit Suisse's Q2 2021 Portfolio in Review

As of Q2 2021, Credit Suisse held 4,784 positions worth $189B, down 3.4% from $195B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Credit Suisse withdrew a net $21B in Q2 2021, closing 388 positions and reducing 2,137 holdings. Its most notable exit was INPHI CORPORATION, an estimated $356M position sold in full.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Credit Suisse opened a new position in Recursion Pharmaceuticals worth $52.9M.

  • Credit Suisse's largest Q2 2021 buy was Recursion Pharmaceuticals: 1,449,585 shares worth $52.9M.
  • Credit Suisse added most to iShares Core S&P 500 ETF in Q2 2021, an estimated $826M increase.
  • Credit Suisse's biggest Q2 2021 reduction was Alibaba, cutting an estimated $1.27B.
  • Credit Suisse fully exited INPHI CORPORATION in Q2 2021, selling an estimated $356M.
  • Credit Suisse's ten largest holdings make up 17% of its $189B portfolio in Q2 2021.
  • Credit Suisse opened 635 new positions and closed 388 in Q2 2021.
  • Credit Suisse's portfolio value fell 3.4% quarter-over-quarter to $189B.

Based on Credit Suisse's 13F filing for Q2 2021, filed 16 Aug 2021.